BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 12516291)

  • 1. Case for diagnosis. Sclerodermiform manifestations of porphyria cutanea tarda secondary to hepatitis C.
    Calado JOA; Bastos LMH; Miot HA
    An Bras Dermatol; 2019; 94(4):479-481. PubMed ID: 31644627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Porphyria cutanea tarda in two patients treated with hemodialysis for chronic renal failure.
    Poh-Fitzpatrick MB; Bellet N; DeLeo VA; Grossman ME; Bickers DR
    N Engl J Med; 1978 Aug; 299(6):292-4. PubMed ID: 661929
    [No Abstract]   [Full Text] [Related]  

  • 3. Hepatitis C and kidney disease.
    Hayat A; Mitwalli A
    Hepat Res Treat; 2010; 2010():534327. PubMed ID: 21188196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re: Porphyria Cutanea Tarda in a Patient with Myelofibrosis.
    Dos Santos VM; Sugai TAM
    Sultan Qaboos Univ Med J; 2023 Aug; 23(3):425-426. PubMed ID: 37655091
    [No Abstract]   [Full Text] [Related]  

  • 5. Porphyria cutanea tarda occurring in a patient with renal failure, systemic lupus erythematosus and chronic hepatitis C infection treated with hemodialysis.
    Lee PK; Abrahams I; Bickers DR
    Cutis; 1999 Oct; 64(4):237-9. PubMed ID: 10544877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Porphyria cutanea tarda in a hemodialysis patient with hepatitis C virus: efficacy of treatment with multiple phlebotomies and erythropoietin.
    Hamzi MA; Alayoud A; Asseraji M; Akhmouch I; Oualim Z
    Saudi J Kidney Dis Transpl; 2013 Jan; 24(1):121-3. PubMed ID: 23354206
    [No Abstract]   [Full Text] [Related]  

  • 7. High prevalence of hepatitis C virus type 1b in Italian patients with Porphyria cutanea tarda.
    Sampietro M; Fracanzani AL; Corbetta N; Amato M; Mattioli M; Molteni V; Fiorelli G; Fargion S
    Ital J Gastroenterol Hepatol; 1997 Dec; 29(6):543-7. PubMed ID: 9513830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The additive effects of hepatitis C infection and end-stage renal disease in porphyria cutanea tarda.
    Chan OT; Tsai N; Wong RL; Izumi AK
    Cutis; 2006 Dec; 78(6):397-400. PubMed ID: 17243426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Porphyria cutanea tarda, hemodialysis and HCV hepatopathy].
    Muray S; Casanova JM; Marco MP; Craver L; Martín M; Fernández E
    Nefrologia; 2002; 22(6):570-3. PubMed ID: 12516291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of porphyria cutanea tarda in the setting of chronic renal failure: a case report and review.
    Shieh S; Cohen JL; Lim HW
    J Am Acad Dermatol; 2000 Apr; 42(4):645-52. PubMed ID: 10727312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Porphyria cutanea tarda in hemodialyzed patients].
    Suga C; Ikezawa Z
    Nihon Rinsho; 1995 Jun; 53(6):1484-90. PubMed ID: 7616666
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.